Arcadia Biosciences, Inc.
RKDA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $5,892 | $4,057 | $8,073 |
| - Cash | $1,120 | $1,376 | $3,159 | $4,242 |
| + Debt | $0 | $11 | $21 | $155 |
| Enterprise Value | – | $4,527 | $919 | $3,986 |
| Revenue | $1,302 | $1,455 | $1,200 | $1,216 |
| % Growth | -10.5% | 21.3% | -1.3% | – |
| Gross Profit | $418 | $631 | $518 | $389 |
| % Margin | 32.1% | 43.4% | 43.2% | 32% |
| EBITDA | $858 | -$1,486 | -$1,207 | -$2,258 |
| % Margin | 65.9% | -102.1% | -100.6% | -185.7% |
| Net Income | $856 | -$4,458 | $2,599 | -$4,064 |
| % Margin | 65.7% | -306.4% | 216.6% | -334.2% |
| EPS Diluted | 0.62 | -3.26 | 1.9 | -1.18 |
| % Growth | 119% | -271.6% | 261% | – |
| Operating Cash Flow | -$257 | -$2,033 | -$1,588 | -$2,209 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$257 | -$2,033 | -$1,588 | -$2,209 |